Rectrospect - a Retrospective Study of Treatment Response
NCT ID: NCT04787523
Last Updated: 2023-11-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
170 participants
OBSERVATIONAL
2020-10-01
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patient data and outcome regarding response to treatment will be collected from patient charts and the Swedish ColoRectal Cancer Registry, but all data will be numbered with the same code number and all results will be kept away from the code list. In order to achieve the stated aims, that is, to study how the molecular and cellular characteristics of the tumour and its surrounding microenvironment as well as the interaction of tumour cells and immune cells affect treatment response, several molecular and cellular techniques and assays may be applied.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Watch and Wait as Treatment for Patients With Rectal Cancer
NCT03125343
MRI Imaging or CT Abdomen as Standard Work-up Before Treatment Planning for Rectal Cancer?
NCT03463616
Concurrent Chemoradiation With Concomitant Boost In Locally Advanced Rectal Cancer
NCT02723253
Genotype-directed Neoadjuvant Chemoradiation for Rectal Carcinoma
NCT00682786
Short Course Radiotherapy, Unresectable Rectal Cancer, Liver Metastasis
NCT03022734
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with pathological response to treatment
Response evaluated using the pathology report
Radiotherapy
Patients have received neoadjuvant radiotherapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Radiotherapy
Patients have received neoadjuvant radiotherapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sahlgrenska University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eva Angenete
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dept. of Surgery, Sahlgrenska University Hospital/Ostra
Gothenburg, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Rectrospect
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.